The allogeneic cell therapy market is projected to grow from USD 614.46 million in 2024 to USD 1,806.84 million by 2032, reflecting a compound annual growth rate (CAGR) of 13.90%.Allogeneic cell therapy is emerging as a revolutionary approach in the field of regenerative medicine and immunotherapy. Unlike autologous cell therapies, which use a patient's own cells, allogeneic cell...